Insider Trading Alert - CFN, MPWR, LYV, ABC And GDOT Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Jan. 7, 2014, 69 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $528.66 to $7,300,552.00.

Highlighted Stocks Traded by Insiders:

CareFusion (CFN) - FREE Research Report

Leonard Thomas J who is President, Medical Systems at CareFusion sold 1,250 shares at $39.48 on Jan. 7, 2014. Following this transaction, the President, Medical Systems owned 59,799 shares meaning that the stake was reduced by 2.05% with the 1,250-share transaction.

The shares most recently traded at $39.95, up $0.47, or 1.18% since the insider transaction. Historical insider transactions for CareFusion go as follows:

  • 4-Week # shares sold: 1,250
  • 12-Week # shares sold: 37,500
  • 24-Week # shares sold: 100,800

The average volume for CareFusion has been 1.4 million shares per day over the past 30 days. CareFusion has a market cap of $8.4 billion and is part of the health care sector and health services industry. Shares are up 0.53% year-to-date as of the close of trading on Tuesday.

CareFusion Corporation, a medical technology company, provides various healthcare products and services. It offers product lines in the areas of medication management, infection prevention, operating room effectiveness, respiratory care, and surveillance and analytics. The company has a P/E ratio of 23.1. Currently there are 5 analysts that rate CareFusion a buy, no analysts rate it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CFN - FREE

TheStreet Quant Ratings rates CareFusion as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels and expanding profit margins. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full CareFusion Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Monolithic Power Systems (MPWR) - FREE Research Report

Xiao Deming who is Pres. of MPS Asia Operations at Monolithic Power Systems sold 5,164 shares at $33.94 on Jan. 7, 2014. Following this transaction, the Pres. of MPS Asia Operations owned 62,907 shares meaning that the stake was reduced by 7.59% with the 5,164-share transaction.

Hsing Michael who is Ceo at Monolithic Power Systems sold 20,000 shares at $34.02 on Jan. 7, 2014. Following this transaction, the Ceo owned 308,436 shares meaning that the stake was reduced by 6.09% with the 20,000-share transaction.

The shares most recently traded at $33.90, down $0.12, or 0.36% since the insider transaction. Historical insider transactions for Monolithic Power Systems go as follows:

  • 4-Week # shares sold: 10,643
  • 12-Week # shares sold: 322,418
  • 24-Week # shares sold: 420,632

The average volume for Monolithic Power Systems has been 381,300 shares per day over the past 30 days. Monolithic Power Systems has a market cap of $1.3 billion and is part of the technology sector and electronics industry. Shares are down 2.22% year-to-date as of the close of trading on Tuesday.

Monolithic Power Systems, Inc., a fabless semiconductor company, designs, develops, and markets analog and mixed-signal semiconductors for the communications, computing, consumer, and industrial markets. The company has a P/E ratio of 84.4. Currently there are 6 analysts that rate Monolithic Power Systems a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MPWR - FREE

TheStreet Quant Ratings rates Monolithic Power Systems as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, growth in earnings per share, increase in net income and good cash flow from operations. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Monolithic Power Systems Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Live Nation Entertainment (LYV) - FREE Research Report

Enloe Robert Ted Iii who is Director at Live Nation Entertainment sold 10,000 shares at $20.04 on Jan. 7, 2014. Following this transaction, the Director owned 29,884 shares meaning that the stake was reduced by 25.07% with the 10,000-share transaction.

The shares most recently traded at $20.79, up $0.75, or 3.61% since the insider transaction. Historical insider transactions for Live Nation Entertainment go as follows:

  • 4-Week # shares bought: 1
  • 4-Week # shares sold: 17,762
  • 12-Week # shares bought: 1
  • 12-Week # shares sold: 17,762
  • 24-Week # shares bought: 1
  • 24-Week # shares sold: 796,444

The average volume for Live Nation Entertainment has been 1.1 million shares per day over the past 30 days. Live Nation Entertainment has a market cap of $4.1 billion and is part of the services sector and media industry. Shares are up 5.42% year-to-date as of the close of trading on Tuesday.

Live Nation Entertainment, Inc. operates as a live entertainment company. The company operates through Concerts, Ticketing, Artist Nation, and Sponsorship & Advertising segments. Currently there is 1 analyst that rates Live Nation Entertainment a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on LYV - FREE

TheStreet Quant Ratings rates Live Nation Entertainment as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity, poor profit margins and deteriorating net income. Get the full Live Nation Entertainment Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

AmerisourceBergen (ABC) - FREE Research Report

McGee Henry Wadsworth III who is Director at AmerisourceBergen sold 9,449 shares at $69.62 on Jan. 7, 2014. Following this transaction, the Director owned 10,034 shares meaning that the stake was reduced by 48.5% with the 9,449-share transaction.

The shares most recently traded at $70.88, up $1.26, or 1.78% since the insider transaction. Historical insider transactions for AmerisourceBergen go as follows:

  • 4-Week # shares sold: 824
  • 12-Week # shares sold: 15,824
  • 24-Week # shares sold: 16,696

The average volume for AmerisourceBergen has been 1.5 million shares per day over the past 30 days. AmerisourceBergen has a market cap of $16.1 billion and is part of the services sector and wholesale industry. Shares are up 0.2% year-to-date as of the close of trading on Tuesday.

AmerisourceBergen Corporation sources and distributes pharmaceutical products to healthcare providers, pharmaceutical and biotech manufacturers, and specialty drug patients in the United States and internationally. The stock currently has a dividend yield of 1.35%. The company has a P/E ratio of 33.2. Currently there are 6 analysts that rate AmerisourceBergen a buy, no analysts rate it a sell, and 6 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ABC - FREE

TheStreet Quant Ratings rates AmerisourceBergen as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance and notable return on equity. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full AmerisourceBergen Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Green Dot (GDOT) - FREE Research Report

Aldrich Kenneth C who is Director at Green Dot sold 39,955 shares at $25.03 on Jan. 7, 2014. Following this transaction, the Director owned 227,961 shares meaning that the stake was reduced by 14.91% with the 39,955-share transaction.

The shares most recently traded at $24.46, down $0.57, or 2.32% since the insider transaction. Historical insider transactions for Green Dot go as follows:

  • 4-Week # shares sold: 10,000
  • 12-Week # shares sold: 10,000
  • 24-Week # shares sold: 35,685

The average volume for Green Dot has been 677,600 shares per day over the past 30 days. Green Dot has a market cap of $930.5 million and is part of the services sector and diversified services industry. Shares are down 0.99% year-to-date as of the close of trading on Tuesday.

Green Dot Corporation, together with its subsidiaries, operates as a technology-centric, pro-consumer bank holding company that provides personal banking for the masses. The company has a P/E ratio of 25.7. Currently there are 4 analysts that rate Green Dot a buy, 2 analysts rate it a sell, and 7 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on GDOT - FREE

TheStreet Quant Ratings rates Green Dot as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including deteriorating net income, disappointing return on equity and weak operating cash flow. Get the full Green Dot Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Data for this article provided by Zacks Investment Research

null

More from Markets

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Apple and GE Switch Roles; Musk's Super Control of Tesla Explained -- ICYMI

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Trump May Be More to Blame For Higher Oil Prices Than OPEC

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Dow Falls Over 200 Points as Apple's Slump Offsets Gains in General Electric

Week Ahead: Major Earnings on Tap as Wall Street Readies for Geopolitical Moves

Week Ahead: Major Earnings on Tap as Wall Street Readies for Geopolitical Moves

3 Hot Reads From TheStreet's Top Premium Columnists

3 Hot Reads From TheStreet's Top Premium Columnists